Nonetheless, despite 40 years of high-quality studies, the p53-regulated tumour suppressive programme is still a puzzle, and cell death/cell cycle arrest are still considered among the most relevant regulatory aspects (Fig. 1). Here, TP53 is linked to neoplasm.